Maria-Elena Theoclitou

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2009-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria-Elena Theoclitou. Retrieved from https://idiyas.com/inventor/maria-elena-theoclitou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

Cheshire, GB (2012)
Macclesfield, GB (2009 - 2013)
Cambridge, GB (2017 - 2019)

Company Filing History:

6 out of 1,534

Astrazeneca Ab

patents

Years Active: 2009-2019

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10301267 - Compounds (2019-05-28),

2. 9688640 - Methods of treating cancer with a pyrazole derivative (2017-06-27),

3. 8604022 - N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof (2013-12-10),

4. 8129391 - N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof (2012-03-06),

5. 7737149 - N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof (2010-06-15),

6. 7498333 - Enantiomers of selected fused heterocyclics and uses thereof (2009-03-03),

Title: Innovations by Maria-Elena Theoclitou

Introduction

Maria-Elena Theoclitou is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a total of six patents to her name, her work has the potential to impact medical science profoundly.

Latest Patents

Among her latest patents, Maria-Elena has developed compounds that are crucial in the fight against cancer. One of her notable patents involves a compound of formula (I) or a pharmaceutically acceptable salt thereof. This patent also outlines processes for the manufacture of this compound and its use as a medicament in cancer treatment. Another significant patent focuses on methods of treating cancer with a pyrazole derivative, again detailing a compound of formula (I) and its applications in medical treatments.

Career Highlights

Maria-Elena Theoclitou is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her contributions to pharmaceutical innovations.

Collaborations

Some of her notable coworkers include David Buttar and Kevin Michael Foote. Their collaborative efforts have been instrumental in advancing research and development in their field.

Conclusion

Maria-Elena Theoclitou's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the pharmaceutical industry. Her patents not only showcase her expertise but also hold promise for future medical advancements.

Profile summary based on public USPTO records.